Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Dendritic cells: a critical player in cancer therapy?

Palucka AK, Ueno H, Fay J, Banchereau J.

J Immunother. 2008 Nov-Dec;31(9):793-805. doi: 10.1097/CJI.0b013e31818403bc. Review.

2.

Taming cancer by inducing immunity via dendritic cells.

Palucka AK, Ueno H, Fay JW, Banchereau J.

Immunol Rev. 2007 Dec;220:129-50. Review.

PMID:
17979844
3.

Dendritic cell subsets as vectors and targets for improved cancer therapy.

Palucka K, Ueno H, Roberts L, Fay J, Banchereau J.

Curr Top Microbiol Immunol. 2011;344:173-92. doi: 10.1007/82_2010_48. Review.

4.

Building on dendritic cell subsets to improve cancer vaccines.

Palucka K, Ueno H, Zurawski G, Fay J, Banchereau J.

Curr Opin Immunol. 2010 Apr;22(2):258-63. doi: 10.1016/j.coi.2010.02.010. Epub 2010 Mar 11. Review.

5.

Harnessing dendritic cells to generate cancer vaccines.

Palucka K, Ueno H, Fay J, Banchereau J.

Ann N Y Acad Sci. 2009 Sep;1174:88-98. doi: 10.1111/j.1749-6632.2009.05000.x.

6.

Cancer immunotherapy via dendritic cells.

Palucka K, Banchereau J.

Nat Rev Cancer. 2012 Mar 22;12(4):265-77. doi: 10.1038/nrc3258. Review.

7.

Generation of dendritic cell-tumor cell hybrids by electrofusion for clinical vaccine application.

Trevor KT, Cover C, Ruiz YW, Akporiaye ET, Hersh EM, Landais D, Taylor RR, King AD, Walters RE.

Cancer Immunol Immunother. 2004 Aug;53(8):705-14. Epub 2004 Mar 26.

PMID:
15048588
8.

Recent developments in cancer vaccines.

Palucka K, Ueno H, Banchereau J.

J Immunol. 2011 Feb 1;186(3):1325-31. doi: 10.4049/jimmunol.0902539. Review.

9.

Cancer vaccines for established cancer: how to make them better?

Andrews DM, Maraskovsky E, Smyth MJ.

Immunol Rev. 2008 Apr;222:242-55. doi: 10.1111/j.1600-065X.2008.00612.x. Review.

PMID:
18364006
10.
11.

Cancer immunotherapy by fusions of dendritic cells and tumor cells.

Koido S, Hara E, Homma S, Ohkusa T, Gong J, Tajiri H.

Immunotherapy. 2009 Jan;1(1):49-62. doi: 10.2217/1750743X.1.1.49. Review.

PMID:
20635973
12.

Dendritic cells in cancer immunotherapy: vaccines or autologous transplants?

Kalinski P, Edington H, Zeh HJ, Okada H, Butterfield LH, Kirkwood JM, Bartlett DL.

Immunol Res. 2011 Aug;50(2-3):235-47. doi: 10.1007/s12026-011-8224-z.

13.
14.

Immunotherapy of autologous tumor lysate-loaded dendritic cell vaccines by a closed-flow electroporation system for solid tumors.

Kamigaki T, Kaneko T, Naitoh K, Takahara M, Kondo T, Ibe H, Matsuda E, Maekawa R, Goto S.

Anticancer Res. 2013 Jul;33(7):2971-6.

PMID:
23780988
15.

Dendritic-cell immunotherapy: from ex vivo loading to in vivo targeting.

Tacken PJ, de Vries IJ, Torensma R, Figdor CG.

Nat Rev Immunol. 2007 Oct;7(10):790-802. Review.

PMID:
17853902
16.

CCL3 and CCL20-recruited dendritic cells modified by melanoma antigen gene-1 induce anti-tumor immunity against gastric cancer ex vivo and in vivo.

He S, Wang L, Wu Y, Li D, Zhang Y.

J Exp Clin Cancer Res. 2010 Apr 27;29:37. doi: 10.1186/1756-9966-29-37.

17.

Dendritic cell-based combined immunotherapy with autologous tumor-pulsed dendritic cell vaccine and activated T cells for cancer patients: rationale, current progress, and perspectives.

Morisaki T, Matsumoto K, Onishi H, Kuroki H, Baba E, Tasaki A, Kubo M, Nakamura M, Inaba S, Yamaguchi K, Tanaka M, Katano M.

Hum Cell. 2003 Dec;16(4):175-82. Review.

PMID:
15147037
18.

Immunogenicity of dendritic-tumor fusion hybrids and their utility in cancer immunotherapy.

Shu S, Zheng R, Lee WT, Cohen PA.

Crit Rev Immunol. 2007;27(5):463-83. Review.

PMID:
18197808
19.

Targeting the immunoregulator SRA/CD204 potentiates specific dendritic cell vaccine-induced T-cell response and antitumor immunity.

Yi H, Guo C, Yu X, Gao P, Qian J, Zuo D, Manjili MH, Fisher PB, Subjeck JR, Wang XY.

Cancer Res. 2011 Nov 1;71(21):6611-20. doi: 10.1158/0008-5472.CAN-11-1801. Epub 2011 Sep 13.

20.

Conference scene: immune effector mechanisms in tumor immunity.

Sikora AG, Hailemichael Y, Overwijk WW.

Immunotherapy. 2012 Feb;4(2):141-3. doi: 10.2217/imt.11.177.

Items per page

Supplemental Content

Write to the Help Desk